GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus

GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group

Research output: Contribution to journalReview article

Abstract

The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) chikungunya (CHIKV), o'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group has been established to identify gaps of knowledge about the natural history, epidemiology and medical management of infection by these viruses, and to provide adapted recommendations for future investigations. Here, we present a report dedicated to ONNV epidemiological distribution. Two large-scale ONNV outbreaks have been identified in Africa in the last 60 years, interspersed with sporadic serosurveys and case reports of returning travelers. The assessment of the real scale of ONNV circulation in Africa remains a difficult task and surveillance studies are necessary to fill this gap. The identification of ONNV etiology is made complicated by the absence of multiplex tools in co-circulation areas and that of reference standards, as well as the high cross-reactivity with related pathogens observed in serological tests, in particular with CHIKV. This is a specific obstacle for seroprevalence studies, that necessitate an improvement of serological tools to provide robust results. The scarcity of existent genetic data currently limits molecular epidemiology studies. ONNV epidemiology would also benefit from reinforced entomological and environmental surveillance. Finally, the natural history of the disease deserves to be further investigated, with a specific attention paid to long-term complications. Considering our incomplete knowledge on ONNV distribution, GloPID-R CHIKV, ONNV and MAYV experts recommend that a major effort should be done to fill existing gaps.

Original languageEnglish (US)
Article number104611
JournalAntiviral research
Volume172
DOIs
StatePublished - Dec 2019

Fingerprint

Epidemiology
Viruses
Molecular Epidemiology
Environmental Monitoring
Seroepidemiologic Studies
Serologic Tests
Virus Diseases
Natural History
Disease Outbreaks
Communicable Diseases
Research

ASJC Scopus subject areas

  • Pharmacology
  • Virology

Cite this

GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2 : Epidemiological distribution of o'nyong-nyong virus. / GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group.

In: Antiviral research, Vol. 172, 104611, 12.2019.

Research output: Contribution to journalReview article

@article{f46e8391f22d4ea68193995a7347a276,
title = "GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus",
abstract = "The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) chikungunya (CHIKV), o'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group has been established to identify gaps of knowledge about the natural history, epidemiology and medical management of infection by these viruses, and to provide adapted recommendations for future investigations. Here, we present a report dedicated to ONNV epidemiological distribution. Two large-scale ONNV outbreaks have been identified in Africa in the last 60 years, interspersed with sporadic serosurveys and case reports of returning travelers. The assessment of the real scale of ONNV circulation in Africa remains a difficult task and surveillance studies are necessary to fill this gap. The identification of ONNV etiology is made complicated by the absence of multiplex tools in co-circulation areas and that of reference standards, as well as the high cross-reactivity with related pathogens observed in serological tests, in particular with CHIKV. This is a specific obstacle for seroprevalence studies, that necessitate an improvement of serological tools to provide robust results. The scarcity of existent genetic data currently limits molecular epidemiology studies. ONNV epidemiology would also benefit from reinforced entomological and environmental surveillance. Finally, the natural history of the disease deserves to be further investigated, with a specific attention paid to long-term complications. Considering our incomplete knowledge on ONNV distribution, GloPID-R CHIKV, ONNV and MAYV experts recommend that a major effort should be done to fill existing gaps.",
author = "{GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group} and L. Pezzi and LaBeaud, {A. D.} and Reusken, {C. B.} and Drexler, {J. F.} and N. Vasilakis and M. Diallo and F. Simon and T. Jaenisch and P. Gallian and A. Sall and Failloux, {A. B.} and Weaver, {S. C.} and {de Lamballerie}, X. and S. Boyer and P. Brasil and M. Busch and Diamond, {M. S.} and Drebot, {M. A.} and A. Kohl and M. Lecuit and R. Louren{\cc}o-de-Oliveira and J. Neyts and Ng Lfp and Ribeiro, {G. S.} and M. Rios and Rodriguez-Morales, {A. J.} and Rosa-Freitas, {M. G.} and G. Simmons and Siqueira, {A. M.} and {Vega Rua}, A.",
year = "2019",
month = "12",
doi = "10.1016/j.antiviral.2019.104611",
language = "English (US)",
volume = "172",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",

}

TY - JOUR

T1 - GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2

T2 - Epidemiological distribution of o'nyong-nyong virus

AU - GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group

AU - Pezzi, L.

AU - LaBeaud, A. D.

AU - Reusken, C. B.

AU - Drexler, J. F.

AU - Vasilakis, N.

AU - Diallo, M.

AU - Simon, F.

AU - Jaenisch, T.

AU - Gallian, P.

AU - Sall, A.

AU - Failloux, A. B.

AU - Weaver, S. C.

AU - de Lamballerie, X.

AU - Boyer, S.

AU - Brasil, P.

AU - Busch, M.

AU - Diamond, M. S.

AU - Drebot, M. A.

AU - Kohl, A.

AU - Lecuit, M.

AU - Lourenço-de-Oliveira, R.

AU - Neyts, J.

AU - Lfp, Ng

AU - Ribeiro, G. S.

AU - Rios, M.

AU - Rodriguez-Morales, A. J.

AU - Rosa-Freitas, M. G.

AU - Simmons, G.

AU - Siqueira, A. M.

AU - Vega Rua, A.

PY - 2019/12

Y1 - 2019/12

N2 - The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) chikungunya (CHIKV), o'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group has been established to identify gaps of knowledge about the natural history, epidemiology and medical management of infection by these viruses, and to provide adapted recommendations for future investigations. Here, we present a report dedicated to ONNV epidemiological distribution. Two large-scale ONNV outbreaks have been identified in Africa in the last 60 years, interspersed with sporadic serosurveys and case reports of returning travelers. The assessment of the real scale of ONNV circulation in Africa remains a difficult task and surveillance studies are necessary to fill this gap. The identification of ONNV etiology is made complicated by the absence of multiplex tools in co-circulation areas and that of reference standards, as well as the high cross-reactivity with related pathogens observed in serological tests, in particular with CHIKV. This is a specific obstacle for seroprevalence studies, that necessitate an improvement of serological tools to provide robust results. The scarcity of existent genetic data currently limits molecular epidemiology studies. ONNV epidemiology would also benefit from reinforced entomological and environmental surveillance. Finally, the natural history of the disease deserves to be further investigated, with a specific attention paid to long-term complications. Considering our incomplete knowledge on ONNV distribution, GloPID-R CHIKV, ONNV and MAYV experts recommend that a major effort should be done to fill existing gaps.

AB - The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) chikungunya (CHIKV), o'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group has been established to identify gaps of knowledge about the natural history, epidemiology and medical management of infection by these viruses, and to provide adapted recommendations for future investigations. Here, we present a report dedicated to ONNV epidemiological distribution. Two large-scale ONNV outbreaks have been identified in Africa in the last 60 years, interspersed with sporadic serosurveys and case reports of returning travelers. The assessment of the real scale of ONNV circulation in Africa remains a difficult task and surveillance studies are necessary to fill this gap. The identification of ONNV etiology is made complicated by the absence of multiplex tools in co-circulation areas and that of reference standards, as well as the high cross-reactivity with related pathogens observed in serological tests, in particular with CHIKV. This is a specific obstacle for seroprevalence studies, that necessitate an improvement of serological tools to provide robust results. The scarcity of existent genetic data currently limits molecular epidemiology studies. ONNV epidemiology would also benefit from reinforced entomological and environmental surveillance. Finally, the natural history of the disease deserves to be further investigated, with a specific attention paid to long-term complications. Considering our incomplete knowledge on ONNV distribution, GloPID-R CHIKV, ONNV and MAYV experts recommend that a major effort should be done to fill existing gaps.

UR - http://www.scopus.com/inward/record.url?scp=85072754013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072754013&partnerID=8YFLogxK

U2 - 10.1016/j.antiviral.2019.104611

DO - 10.1016/j.antiviral.2019.104611

M3 - Review article

C2 - 31545982

AN - SCOPUS:85072754013

VL - 172

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

M1 - 104611

ER -